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Abstract 
We describe the preparation of monodisperse, lanthanide-doped hexagonal-phase NaYF4 up-
converting luminescent nanoparticles for protein conjugation. Their core was coated with a silica 
shell which then was modified with a poly(ethylene glycol) spacer and N-hydroxysuccinimide ester 
groups. The nanoparticles were characterized by transmission electron microscopy, Raman 
spectroscopy, X-ray diffraction, and dynamic light scattering. The N-hydroxysuccinimide ester 
functionalization renders them highly reactive towards amine nucleophiles (e.g., proteins). We 
show that such particles can be conjugated to proteins. The protein-reactive UCLNPs and their 
conjugates to streptavidin and bovine serum albumin display multicolor emissions upon 980-nm 
continuous wave laser excitation. Surface plasmon resonance studies were carried out to prove 
bioconjugation and to compare the affinity of the particles for proteins immobilized on a thin gold 
film. 
Key words: Upconversion luminescence, nanoparticle, silica coating, Raman spectroscopy, bio-
sensing, magnetic separation, surface plasmon resonance. 
Introduction 
The implementation of nanotechnology to 
healthcare holds great promise in areas such as im-
aging [1,2,3,4,5], faster diagnosis [6], targeting [7], 
drug delivery [8], and tissue regeneration [9], as well 
as the development of medical products [10,11,12]. 
The chemical synthesis of NPs has been studied in 
detail during the last decade [13,14,15,16]. Substantial 
efforts have been made to control the dimensions, 
shape, composition, particle size distribution, etc., of 
NPs, thereby creating new materials with size de-
pendent electrical, optical, magnetic, catalytic, and 
chemical properties, which cannot be achieved by 
their bulk counterparts. Important classes of NPs are 
a) magnetic NPs, b) gold NPs, c) quantum dots, d) 
silica NPs, etc. [17,18,19,20,21,22,23]. In recent years, 
upconverting luminescent nanoparticles (UCLNPs) 
joined this classification. Photon upconversion has 
been researched ever since the 1960s. It is a process 
where two or more photons are sequentially ab-
sorbed, resulting in the emission of light at a shorter 
wavelength than the excitation light. For instance, 
infrared or near-infrared (NIR) light can be converted 
to shorter-wavelength radiation, usually in the visible 
range of the electromagnetic spectrum (anti-Stokes 
type emission) [24].  
 The mechanisms behind photon upconversion 
were first investigated in lanthanide-doped bulk ma-
terials by Auzel, Ovsyankin, and Feofilov [25]. In a 
sensitizer/activator system, the excitation energy is 
absorbed by a sensitizer ion (e.g., Yb3+) and trans-
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ferred to an activator ion (e.g., Er3+ or Tm3+) via a 
non-radiative, resonant energy transfer process. Met-
astable, long-lived energy states are required, in 
which case energy transfer upconversion (ETU) is 
possible, where the combined energies of pump pho-
tons are stored, which can lead to the emission of a 
higher energy photon [26].  
 Anti-Stokes emissions from UCLNPs offer sev-
eral advantages over conventional Stokes-shifted 
emissions from a) semiconductor quantum dots, b) 
organic- and protein-based fluorophores, and c) the 
multiphoton process employing fluorescent dyes. 
UCLNPs are very attractive phosphors in terms of 
bioimaging due to their nonblinking emission and 
remarkable photostability [27 , 28 ,29 ]. In biological 
samples or tissue, there is minimal excitation of auto-
fluorophores, since UCLNPs are usually excited by 
NIR (980 nm) continuous wave (cw) laser light. This 
scheme enables luminescence to be imaged with a 
high signal to noise ratio, minimizes possible photo-
damage in biological systems, and allows deeper tis-
sue penetration [30,31]. Upconversion microparticles 
have been used before in immunoassays [32] and en-
zyme activity assays [33], but their size (1 – 10 µm) 
and large size distribution makes their use less attrac-
tive. With respect to the relative size of a protein and 
upconversion microparticles, one may not speak of a 
label in its classical sense.  
 High-quality UCLNPs (with respect to crystal 
phase, monodispersity, geometry, etc.) are usually 
synthesized in high-boiling organic solvents (e.g., 
1-octadecene) using ligand molecules with long alkyl 
chains (e.g., oleic acid), which renders them inher-
ently functionalized with hydrophobic alkyl groups 
and only dispersible in non-polar organic solvents 
such as toluene, hexane, and the like [34,35]. In order 
to make them amenable to bioanalytical applications, 
surface modification is required, to make the UCLNPs 
water dispersible, offering a platform for further 
conjugation of functional chemical groups and/or 
(bio)-molecules. Silica is known for its biocompatibil-
ity [36], and silica coating of UCLNPs therefore offers 
an attractive way of functionalization [37,38]. This has 
already been applied to a multitude of nanoparticle 
systems, including gold and silver NPs [39], magnetic 
NPs [40], and quantum dots [41]. In addition, silica 
coating is a flexible coating technique that is applica-
ble to both hydrophilic and hydrophobic NPs 
[42,43,44]. The coating process of hydrophilic NPs 
relies on the Stöber method, while a re-
verse-microemulsion method is typically 
used for coating hydrophobic NPs [45]. 
 We describe the synthesis of pro-
tein-reactive, multicolor UCLNPs. First, 
monodisperse, lanthanide-doped hex-
agonal-phase NaYF4 nanoparticles were 
prepared, which were coated with oleic 
acid, as can be seen in Scheme 1.  
 
 
Figure S1. (Scheme 1). Surface engineering of 
UCLNPs towards protein-reactive, multicolor 
upconverting labels. 
 
 
In the second step, the particles 
were silica coated using a re-
verse-microemulsion method, and sub-
sequently functionalized with an ami-
no-reactive silanization reagent. This 
reagent consists of a triethoxysilane 
conjugated to a poly(ethylene glycol) 
spacer (PEG) and a carboxyl group acti-
vated with an N-hydroxysuccinimide 
(NHS) ester. The NHS ester of the sili-
ca-coated UCLNPs renders them highly 
reactive towards proteins. The pro-
tein-reactive UCLNPs exhibit multicolor 
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luminescence emission after 980-nm laser excitation. 
Finally, surface plasmon resonance (SPR) studies 
were carried out to study the binding affinity of 
NHS-activated nanoparticles to proteins that previ-
ously were immobilized on a gold film. 
Materials and Methods 
Chemicals 
Yttrium(III) chloride hexahydrate (99.99%), yt-
terbium(III) chloride hexahydrate (99.9%) erbium(III) 
chloride hexahydrate (99.9%), thulium(III) chloride 
hexahydrate (99.99%), ammonium fluoride (ACS re-
agent ≥98.0%), sodium hydroxide (reagent grade 
≥98.0%) , Igepal® CO-520, tetraethyl orthosilicate 
(TEOS), bovine serum albumin (BSA) fraction V (pu-
rity >96% ), 16-mercapto-hexadecanoic acid (95%), 
N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide 
hydrochloride (EDC) commercial grade, and sodium 
chloride (p.A.) were purchased from Sigma-Aldrich 
(www.sigmaaldrich.com), oleic acid (technical grade 
90%) and 1-octadecene (technical grade 90%) from 
Alfa Aesar (www.alfa.com), triethoxysilane 
poly(ethylene glycol) 2000 succinimidyl ester from 
Nanocs (www.nanocs.com), ammonia solution (32%), 
2-propanol (p.A.), 2-amino-2-hydroxymethyl- 
propane-1,3-diol (TRIS, molecular biology grade), 
from Merck (www.merckgroup.com), sodium hy-
drogen carbonate (p.A.) from Ferak (www.ferak.de), 
ethanol (p.A.) from Roth (www.carlroth.de), and 
streptavidin-modified magnetic beads (PureProteo-
meTM) from Millipore (www.millipore.com). All other 
reagents and organic solvents were of the highest 
grade available. 
Instrumentation 
Transmission electron microscopy (TEM) was 
performed using a 120 kV Philips CM12 
(www.fei.com) microscope. Upconversion lumines-
cence spectra were recorded with a luminescence 
spectrometer (LS 50 B) from Perkin Elmer 
(www.perkinelmer.com), modified with a 980-nm cw 
laser (120 mW) from Roithner 
(www.roithner-laser.com) for upconversion pho-
to-excitation. All centrifugation steps were carried out 
in a Hettich Universal 320 centrifuge 
(www.hettichlab.com). Raman spectroscopy was 
performed using a DXR Raman microscope from 
Thermo Scientific (www.thermoscientific.com) with 
532-nm cw laser excitation (8 mW). The Zetasizer 
Nano ZS from Malvern (www.malvern.com) was 
used for dynamic light scattering (DLS) experiments. 
X-ray powder diffraction (XRD) patterns with a reso-
lution of 0.02° (2θ) were collected using a Stoe Stadi P 
diffractometer (www.stoe.com) with a Cu source (Kα 
radiation, λ=1.54060 Å) operating at 40 kV and 42 mA. 
All SPR experiments were performed with a Biosuplar 
6 instrument from Mivitec GmbH, 
(www.biosuplar.com). Typically, glass slides with a 
50 nm thick gold film were used, and intensity meas-
urements were performed at constant angle. The sig-
nal intensity was calibrated in refractive index units 
(RIU) with solutions of sodium chloride of different 
concentrations and known refractive index. 
Synthesis of hydrophobic NaYF4 nanoparticles 
doped with Yb/Er or Yb/Tm 
Two systems of hydrophobic, lanthanide-doped 
NaYF4 nanocrystals were prepared via a modified 
procedure as reported by Zhang et al. [46]. For the 
first system YCl3·6H2O (0.747 mmol), YbCl3·6H2O 
(0.25 mmol), TmCl3·6H2O (0.003 mmol) were em-
ployed. In the second system YCl3·6H2O (0.78 mmol), 
YbCl3·6H2O (0.20 mmol), ErCl3·6H2O (0.02 mmol) 
were used. The salts were dissolved in approximately 
5 mL of methanol by sonication. The respective clear 
and optically transparent solution of rare earth chlo-
rides in methanol was transferred into a 50 mL flask, 
mixed with 8 mL of oleic acid and 15 mL of 
1-octadecene under an atmosphere of nitrogen and 
heated to 160 °C. A homogeneous, clear solution was 
formed after 30 minutes at 160 °C under vacuum. The 
reaction mixture was then cooled to room tempera-
ture and 10 mL of methanol containing NaOH (0.25 
M) and NH4F (0.4 M) were added at once. The col-
loidal dispersion was heated to 120 °C and stirred for 
30 minutes. The resulting colloid was refluxed at ap-
proximately 325 °C for 15 minutes. After cooling to 
room temperature, the UCLNPs were precipitated by 
addition of approximately 20 mL of ethanol and iso-
lated via centrifugation at a relative centrifugal force 
(RCF) of 1000 g for 5 minutes. The pellet was washed 
several times by dispersing it in small amounts (ap-
proximately 0.5 mL) of chloroform and cyclohexane, 
then precipitating them by the addition of a large ex-
cess (approximately 15 mL) of ethanol and acetone. A 
white solid was obtained, which can be easily 
re-dispersed in cyclohexane to form a clear disper-
sion. This was used for further silica coating. 
Silica coating of hydrophobic nanoparticles 
The surface of the hydrophobic UCLNPs was 
coated with silica using a modified re-
verse-microemulsion technique [36]. 10 mg of the 
UCLNPs were dispersed in 10 mL of cyclohexane in a 
25 mL round bottom flask. Then, 500 µL of Igepal® 
CO-520 and 80 µL of an aqueous ammonia solution 
(32%) were added. This yielded a clear and stable 
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emulsion after 30 minutes of sonication, which was 
supplemented with 60 µL (0.27 mmol) of TEOS and 
kept for 24 hours at room temperature under mag-
netic stirring (600 rpm). The silica-coated UCLNPs 
were collected via centrifugation (RCF 3000 g for 5 
minutes). Three cycles of re-dispersion and centrifu-
gation were performed to wash the pellet with an 
ethanol/water mixture (1:1 v/v). The nanoparticles 
were filtered through a syringe filter with a pore size 
of 200 nm and stored in ethanol. 
Functionalization of silica-coated nanoparti-
cles 
A fresh solution of 10 mg of triethoxysilane 
poly(ethylene glycol) 2000 succinimidyl ester in 500 
µL of ethanol was added to a dispersion of 3 mg of 
silica-coated UCLNPs in 200 µL ethanol. The mixture 
was magnetically stirred for 2 hours at room temper-
ature. The succinimidyl-functionalized UCLNPs were 
collected via centrifugation (RCF 17000 g for 10 
minutes), and the unreacted materials were washed 
away with cold distilled water. Thereafter, the suc-
cinimidyl-functionalized UCLNPs were stored in 
2-propanol at 4 °C. 
Conjugation of succinimidyl-functionalized 
nanoparticles to streptavidin-modified mag-
netic beads 
An aliquot (100 µL) of a dispersion of the mag-
netic beads was placed in a microcentrifuge tube. The 
magnetic beads were collected with a permanent 
magnet and washed two times with a hydrogen car-
bonate buffer (HCB) solution (0.1 M) adjusted to pH 9 
with 1 M NaOH. After washing, the magnetic beads 
were dispersed in 500 µL of HCB. In parallel, 1 mg of 
succinimidyl-functionalized UCLNPs in 500 µL of 
2-propanol was collected via centrifugation (RCF 
17000 g for 10 minutes). The supernatant was dis-
carded and 500 µL of HCB were added to the pellet. 
An optically transparent dispersion was obtained 
after sonication. The dispersions of streptavidinylated 
magnetic beads and protein-reactive UCLNPs were 
combined and magnetically stirred at room tempera-
ture for 2 hours. The streptavidin-modified magnetic 
bead UCLNPs conjugate was collected with a per-
manent magnet and washed two times with HCB. 
Conjugation of succinimidyl-functionalized 
nanoparticles to bovine serum albumin 
A self-assembled monolayer of a car-
boxy-terminated alkane thiol was prepared by im-
mersing a gold glass slide overnight in a solution of 
16-mercapto-hexadecanoic acid (400 µM) in ethanol. 
The protein (BSA) was bound to this surface via EDC 
coupling [47]. First, 20 mg of BSA were dissolved in 10 
mL aqueous NaCl solution (140 mM). Second, 480 mg 
of EDC were added and mixed by vortexing. This 
solution was applied to the SPR chip. The binding of 
BSA to the activated carboxy groups was monitored 
in real time by SPR. Changes in the intensity of the 
reflected light were recorded at constant angle. An 
increase in the intensity of the SPR signal over time 
indicated binding of BSA. Saturation had occurred 
after approximately 30 minutes. The chip was washed 
with a solution of sodium chloride (140 mM). Again, 
BSA together with EDC was loaded onto the chip. 
Only a slight increase in the signal could be observed. 
After washing, the signal returned to the starting 
values (prior to the second immobilization). This in-
dicates that surface modification with BSA was suc-
cessful. Next, the solution in the SPR cell was changed 
to HCB. When the signal reached a constant value, 
protein-reactive UCLNPs (1 mg/mL) in HCB were 
added. After 80 minutes, no significant increase in the 
SPR signal was observed. Washing steps with hy-
drochloric acid (0.1 M) for 10 minutes and with HCB 
for 10 minutes led to a decrease in the signal by ap-
proximately 20%. 
Results and Discussion 
The hydrophobic NaYF4 nanoparticles doped 
with Yb/Er and Yb/Tm possess good monodispersity 
and hexagonal crystal phase. They were prepared via 
a modification of a known method [46]. The doping 
concentrations of lanthanide ions are 20/2 mol% for 
doping with Yb/Er, and 25/0.3 mol% for doping with 
Yb/Tm. Lanthanide-doped β-phase NaYF4 displays 
superior brightness compared to other host materials 
[48], which is about one order of magnitude better 
than comparable cubic α-phase NaYF4 UCLNPs 
[46,49]. The upconversion luminescence spectra of the 
corresponding Yb/Er and Yb/Tm-doped samples 
acquired from dispersions in cyclohexane are dis-
played in Figure 1A. Under 980-nm cw laser excita-
tion, the NaYF4(20%Yb/2%Er) nanocrystals yield 
three distinct emission peaks at 522, 541, and 655 nm. 
These are assigned to the 4H11/2 – 4I15/2, 4S3/2 – 4I15/2, 
and 4F9/2 – 4I15/2 transitions of Er3+ ions, respectively 
[45].  
 The spectrum of NaYF4(25%Yb/0.3%Tm) dis-
plays two blue emission peaks (450 and 475 nm), 
which correspond to the 1D2 – 3F4 and 1G4 – 3H6 tran-
sitions of the Tm3+ ions, respectively. Additionally, 
there are two weaker peaks at 646 nm (3F2 – 3F3) and 
696 nm (3H6 – 1G4) [45]. The predominantly blue and 
green emissions of optically transparent colloidal 
dispersions of the corresponding multicolor nanopar-
ticles in cyclohexane upon 980-nm cw laser excitation 
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can be seen in Figure 1B. It shall be mentioned here 
that the luminescence of UCLNPs strongly depends 
on temperature and, in fact, has been used to sense it 
on a nanoscale [50]. 
Dispersions of the UCLNPs in cyclohexane ex-
hibit very good colloidal stability. No sedimentation 
or agglomeration was found even after several weeks. 
Dynamic light scattering (DLS) experiments per-
formed at 25 °C with a 632.6-nm laser and a 
non-invasive backscatter technique confirmed this 
observation. The average hydrodynamic diameter of 
the Yb/Er-doped nanoparticles is 34.4 nm, with a 
full-width at half maximum (FWHM) of 5 nm, this 
yielding a polydispersity index (PI) of 0.072. The re-
spective values for the Yb/Tm-doped UCLNPs are 
31.8 nm for the diameter, 5.3 nm FWHM, and a PI of 
0.048. Excellent correlation statistics and fits (data not 
shown) were obtained using a non-negative least 
squares analysis algorithm.  
 The TEM images of the corresponding nano-
crystals are shown in Figure 2. A dispersion of 
UCLNPs in cyclohexane was dried on a carbon-coated 
copper grid. The roughly spherical nanoparticles form 
a 2D hexagonal closed packing, as can be seen from 
the TEM images. This behavior may be due to 
van-der-Waals interaction of oleic acid (OA) mole-
cules on the particles’ surface and the solid carbon 
support of TEM grids. The average particle diameters 
as determined via TEM are 27 nm for the 
Yb/Er-doped sample and 25 nm for the 
Yb/Tm-doped sample. These results are in good 
agreement with the DLS data, since DLS experiments 
take account of the hydrodynamic diameter of the 
particles rather than their sheer particle size. 
The results of XRD crystal phase analyses are 
shown in Figure 2C, and demonstrate the high crys-
tallinity of the UCLNPs. The XRD patterns of the two 
samples of nanocrystals are in good agreement with 
the standard pattern of β-NaYF4 (ICDD PDF 16-334). 
Raman spectroscopy was used to characterize the 
phonon bands of the NaYF4 nanocrystals (Figure 3A). 
They are clearly visible and distinct between 225 – 450 
cm-1. The weighed average of the phonon modes is 
304 cm-1 for the Yb/Er-doped sample, and 320 cm-1 for 
the Yb/Tm-doped sample. This phonon energy is 
considerably lower than that of comparable fluoride 
host lattices such as LiYF4 (570 cm-1) [51,52]. Addi-
tionally, it is predictably lower than that of bulk, 
un-doped NaYF4 (360 cm-1) [53] due to the modified 
phonon density of states [54]. Oleic acid has a distinct 
Raman spectrum in the 2830 – 2960 cm-1 region where 
CH2 stretching modes are observed. These are partic-
ularly susceptible to thermal changes, and slight 
spectral variations are expected from sample to sam-
ple for this reason [55]. The Raman spectra for this 
spectral region are shown in Figure 3B. Additional 
evidence of the presence of OA is exhibited by the 
strong CH2 scissoring modes in the 1438 – 1456 cm-1 
region (not shown here). Other (but much weaker) 
Raman peaks for oleic acid can be observed in the 600 
– 1800 cm-1 region. 
 
 
 
Figure 1. (A) Normalized upconversion luminescence spectra of Yb/Tm (dotted blue line) and Yb/Er-doped (solid green line) multicolor 
β-NaYF4 nanocrystals. The UCLNPs were dispersed in cyclohexane (1 mg/mL). (B) Digital photograph of optically transparent colloidal 
dispersions of corresponding UCLNPs (1 mg/mL) in cyclohexane. The predominantly blue and green emissions of Yb/Tm and Yb/Er-doped 
UCLNPs upon 980-nm cw laser excitation can easily be seen by the bare eye. 
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Figure 2. TEM images of NaYF4(20%Yb/2%Er) (A) and NaYF4(25%Yb/0.3%Tm) (B) upconversion luminescent nanoparticles, respectively. 
Scale bar: 100 nm. Graph (C) shows the corresponding XRD patterns and the standard XRD pattern of β-NaYF4 (ICDD PDF 16-334). 
 
 
Figure 3. Raman spectra of UCLNPs focusing on the NaYF4 phonon region (A), and the CH2 stretching corresponding to the func-
tionalized OA (B). The dotted blue line corresponds to the Yb/Tm-doped sample and the solid green line to the Yb/Er-doped UCLNPs. 
The Raman spectrum of pure, non-functionalized OA (solid grey line) is shown in (B) for comparison. The slight peak shifts and difference 
in peak widths between the non-functionalized OA and the OA-functionalized UCLNPs indicate that OA is likely to be bound to the 
surface of UCLNPs. 
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Figure 4. TEM images of silica-coated upconversion luminescent nanoparticles (UCLNPs) of the type NaYF4(20%Yb/2%Er)@silica (A) 
and of the type NaYF4(25%Yb/0.3%Tm)@silica (B) in water (1 mg/mL) before functionalization with PEG2000-NHS. The sample was 
prepared by dropping an aliquot of approximately 2 µL of silica-coated UCLNPs dispersion onto the surface of a carbon-coated copper 
grid. Scale bar: 100 nm. The normalized upconversion luminescence spectra of silica-coated Yb/Tm (dotted blue line) and Yb/Er-doped, 
β-NaYF4 nanocrystals (solid green line) are shown in (C). The Raman spectra of UCLNPs with silica (solid lines) and without silica (dotted 
lines) are shown in (D). The same conditions were maintained in all experiments. 
 
The hydrophobic, oleic acid-coated UCLNPs 
were then silica coated via a reverse-microemulsion 
technique according to a modified literature method 
[36]. This makes them water dispersible and biocom-
patible, which is a prerequisite for almost any bioap-
plications. The TEM images in Figure 4 demonstrate 
that this technique yields a thin and uniform silica 
coating on the hydrophobic nanoparticles. The for-
mation of a silica shell can be clearly deduced from 
the TEM images, because silica exhibits an electron 
optical contrast which is quite different from that of 
rare earth-doped nanocrystals. The size of the 
Yb/Er-doped nanoparticles increased from 27 to 38 
nm after silica coating, implying a shell thickness of 
approximately 5 nm. The diameter of the respective 
Yb/Tm-doped particles increased from 25 to 38 nm, 
and this corresponds to a shell thickness of about 6 
nm.  
 The normalized upconversion luminescence 
spectra of Yb/Er and Yb/Tm-doped, silica coated, 
multicolor particles dispersed in deionized water so-
lution are shown in Figure 4C. The silica-coated 
nanocrystals also exhibit a Raman peak at 1381 cm-1 as 
shown in Figure 4D. This band is not present for the 
uncoated nanoparticles, and is likely to be due to the 
Si-CH2 scissoring mode [56]. 
In the next step, a silane reagent with a PEG2000 
spacer and activated as an N-hydroxysuccinimide 
(NHS) ester was covalently bound to the surface via a 
silanization technique [57]. The PEG spacer is benefi-
cal in that it can prevent agglomeration, reduce un-
specific binding, and improve solubility in water. The 
NHS ester groups render the silica-coated UCLNPs 
highly reactive towards proteins, as shown by label-
ing of streptavidin-modified magnetic beads.  
 We have attempted to calculate the number of 
NHS groups on a nanocrystal. In order to do so, the 
following assumptions have been made:  (a) The av-
erage radius of the nanocrystals is 19 nm. 
(b) The average radius of a (spherical) PEG 2000 
molecule is approximately 1.5 nm [58] The volume of 
a spherical nanocrystal with a radius of 19 nm can be 
calculated to be 29 µm³, and the volume of a spherical 
PEG 2000 molecule with a radius of 1.5 nm to be 14 
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nm³. The total volume of a spherical nanocrystal 
loaded with PEG 2000 is 45 µm³. The number of PEG 
2000 molecules can be calculated if the difference (45 
µm³ - 29 µm³) is divided by 14 nm³ and yields about 
1100 NHS groups per (spherical) silica coated nano-
crystal. We have to stress here that this is a rough 
number only and also presume that the number of 
NHS groups per nanocrystal can be governed (re-
duced) by using mixtures of PEG2000-NHS reagent 
and PEG2000-modified silyl reagent (without NHS 
groups), but this has not been verified experimentally. 
 Two sets of experiments were carried out. In a 
first (positive control) experiment, the streptavidinyl-
ated magnetic beads were mixed with UCLNP NHS 
esters in a conjugation buffer (HCB) of pH 9. After 2 
hours at room temperature, the magnetic beads were 
collected with a permanent magnet and washed with 
HCB. The collected spot of streptavidin-modified 
magnetic beads was identified by its upconversion 
luminescence upon 980-nm cw laser excitation (Figure 
5A). This proves that the protein-reactive multicolor 
UCLNPs bind to streptavidin. In a second (negative 
control) experiment, the UCLNP NHS esters were 
previously deactivated by reacting them with the 
amino groups of TRIS buffer solution (2 mM, pH 8.5) 
overnight at room temperature. The first experiment 
was then repeated with the deactivated nanoparticles. 
Indeed, the upconversion luminescence of the col-
lected cluster of streptavidin-modified magnetic 
beads was not observed. This fact proves that the de-
activated particles are not bound to the streptavi-
dinylated magnetic beads. On the other hand, a dis-
persion of the unreactive particles also display up-
conversion emission upon 980-nm cw laser excitation 
(Figure 5B). 
 
 
Figure 5. (A; top) Digital photograph of the protein-reactive upconversion luminescent nanoparticles (UCLNPs) bound to streptavi-
din-modified magnetic beads (2), collected with a permanent magnet (1) upon 980-nm cw laser (3) excitation (280 mW) in a hydrogen 
carbonate buffer. (B; top) Photograph illustrating that UCLNP NHS esters that were deactivated by reaction with Tris buffer and dis-
persed in a hydrogen carbonate buffer do not bind to streptavidinylated magnetic beads (2). (C; bottom) SPR results showing the un-
specific binding of deactivated UCLNPs (dotted red line) and specific binding of protein-reactive UCLNPs (solid black line) to BSA im-
mobilized on a gold substrate. The curves show the addition of the respective UCLNPs in a hydrogen carbonate buffer (a), and the 
washing steps with hydrochloric acid (0.1 M, b), and hydrogen carbonate buffer solution (c). 
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In order to quantitatively verify the functionality 
of protein-reactive nanoparticles, their binding to 
surface-immobilized BSA was monitored by SPR 
measurements in real time. SPR provides a 
well-known label free method to study interaction of 
biomolecules on thin gold films [59]. We coated the 
thin gold surface with a monolayer of a car-
boxy-terminated alkanethiol. The protein was immo-
bilized via EDC coupling onto this surface. The bind-
ing of protein-reactive NPs to BSA was studied by 
measuring the shift in the surface plasmon resonance. 
Therefore, one can either measure the angle of mini-
mum reflection of the light as a function of time, or 
monitor the time-dependent change in the intensity of 
the reflected light at a constant angle of incidence. The 
kinetics for binding of the nanoparticles to the protein 
layer can be seen in Figure 5C. Both the pro-
tein-reactive and the deactivated UCLNPs bind to 
BSA. After washing with 0.1 mM hydrochloric acid 
for 10 minutes and then with hydrogen carbonate 
buffer for another 10 minutes, it can be clearly seen 
that the protein-reactive particles still bind quite 
strongly. Some deactivated particles also bind due to 
non-specific binding. On the other hand, when using 
nanoparticles with a silica shell without NHS groups, 
we also see unspecific binding, but the particles can be 
simply washed off with buffer.  
Conclusion 
We report here on the preparation of monodis-
perse, multicolor UCLNPs with controlled diameters 
of ~26 nm using a modified solvothermal method. In 
order to make them amenable to bioanalytical appli-
cations, surface modification was performed by first 
depositing a thin silica shell (~5 nm thick) on the hy-
drophobic nanoparticles, this followed by coating it 
with a poly(ethylene glycol) spacer carrying 
N-hydroxysuccinimide groups. The resulting parti-
cles form stable dispersions in aqueous solution and 
are highly reactive towards proteins such as strep-
tavidin and bovine serum albumin. Such ami-
no-reactive labels form an attractive alternative to 
thiol-reactive UCLNPs [60]. Specifically, the reactive 
UCLNPs were conjugated to streptavidin-modified 
magnetic beads. The magnetic beads labeled with 
streptavidinylated UCLNPs were separated by mag-
netic force and displayed upconversion luminescence 
upon 980-nm laser excitation. We believe that such 
amino-reactive multicolor nanoparticles can be em-
ployed as luminescent labels for various kinds of 
(organic) amines, biogenic amines, proteins, or ami-
no-modified oligomers. Labeled proteins have nu-
merous applications such as in immunoassays, en-
zymatic assays, and in imaging. All these will strongly 
benefit from the use of labels with photon upconver-
sion capability. 
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